Market Cap 17.82M
Revenue (ttm) 31.91M
Net Income (ttm) -26.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -81.73%
Debt to Equity Ratio 0.00
Volume 435,590
Avg Vol 168,130
Day's Range N/A - N/A
Shares Out 52.40M
Stochastic %K 11%
Beta 1.19
Analysts Strong Buy
Price Target $12.00

Latest News on ENZ

Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results

Mar 17, 2025, 4:20 PM EDT - 16 days ago

Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results


Enzo Biochem to pay $4.5 mln for failing to safeguard patient data

Aug 13, 2024, 10:48 AM EDT - 8 months ago

Enzo Biochem to pay $4.5 mln for failing to safeguard patient data


Enzo Biochem: Is This Time Finally Different?

Jul 17, 2024, 12:49 AM EDT - 9 months ago

Enzo Biochem: Is This Time Finally Different?


Enzo Biochem: Cleaned Up And Cash-Rich But Unloved

Oct 26, 2023, 1:18 AM EDT - 1 year ago

Enzo Biochem: Cleaned Up And Cash-Rich But Unloved


Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

Jul 24, 2023, 4:27 PM EDT - 1 year ago

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp


Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

Mar 16, 2023, 4:30 PM EDT - 2 years ago

Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp


Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript

Dec 13, 2022, 9:49 AM EST - 2 years ago

Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript


Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO

Oct 20, 2022, 8:15 AM EDT - 2 years ago

Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO


Enzo Biochem to Launch Monkeypox Testing Services this Week

Aug 11, 2022, 8:00 AM EDT - 2 years ago

Enzo Biochem to Launch Monkeypox Testing Services this Week